Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Chronic Heart Failure

Free Subscription 16.05.2022 3 Am Heart J 1 Cardiovasc Res 2 Clin Cardiol 2 Eur J Heart Fail 2 Int J Cardiol 5 J Cardiovasc Pharmacol 8 J Mol Cell Cardiol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am Heart J

1. LOPEZ-GALVEZ R, Marin F, Rivera-Caravaca JM
   Predicting heart failure in atrial fibrillation patients: What about using biomarkers?
   Am Heart J. 2022 May 7. pii: S0002-8703(22)00092.
   PubMed        
   
   
2. GILSTRAP L, Zipkin RJ, Barnes JA, King A, et al
   Sacubitril/Valsartan vs. ACEi/ARB at Hospital Discharge and 5-Year Survival in Older Patients with Heart Failure with Reduced Ejection Fraction: A Decision Analysis Approach.
   Am Heart J. 2022 May 4. pii: S0002-8703(22)00082.
   PubMed         Abstract available
   
   
3. JENSEN J, Omar M, Ali M, Frederiksen PH, et al
   The Effect of Empagliflozin on Contractile Reserve in Heart Failure: Prespecified Sub-Study of a Randomized, Double-Blind, and Placebo-Controlled Trial.
   Am Heart J. 2022 May 2. pii: S0002-8703(22)00083.
   PubMed         Abstract available
   
   

   
   Cardiovasc Res

4. ROUHI L, Fan S, Cheedipudi SM, Braza-Boils A, et al
   The EP300/TP53 pathway, a suppressor of the Hippo and canonical WNT pathways, is activated in human hearts with arrhythmogenic cardiomyopathy in the absence of overt heart failure.
   Cardiovasc Res. 2022;118:1466-1478.
   PubMed         Abstract available
   
   

   
   Clin Cardiol

5. WANG T, Yu FC, Wei Q, Xu X, et al
   Sleep-disordered breathing in heart failure patients with different etiologies.
   Clin Cardiol. 2022 May 10. doi: 10.1002/clc.23840.
   PubMed         Abstract available
   
   
6. GU G, Wu J, Gao X, Liu M, et al
   Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta-analysis.
   Clin Cardiol. 2022 May 11. doi: 10.1002/clc.23841.
   PubMed         Abstract available
   
   

   
   Eur J Heart Fail

7. KALOGEROPOULOS AP, Tam E
   Intravenous iron in heart failure with reduced ejection fraction: just about right.
   Eur J Heart Fail. 2022 Apr 28. doi: 10.1002/ejhf.2520.
   PubMed        
   
   
8. CARTER S, Hendren NS, Grodin JL
   Sodium-glucose cotransporter 2 inhibition, uric acid, and heart failure: correlation without causation?
   Eur J Heart Fail. 2022 Apr 29. doi: 10.1002/ejhf.2516.
   PubMed        
   
   

   
   Int J Cardiol

9. IWATSU K, Ikeda T, Matsumura K, Ashikawa H, et al
   Gap in the prognostic impact of short physical performance battery among phenotypes of heart failure.
   Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00656.
   PubMed         Abstract available
   
   
10. ANGUITA E, Chaparro A, Candel FJ, Ramos-Acosta C, et al
    Biomarkers of stable and decompensated phases of heart failure with preserved ejection fraction.
    Int J Cardiol. 2022 May 6. pii: S0167-5273(22)00655.
    PubMed         Abstract available
    
    

    
    J Cardiovasc Pharmacol

11. AL-ANI MA, Murray MR, Taha MB, Meece L, et al
    Impact of Laparoscopic Sleeve Gastrectomy on Cardiovascular Pharmacotherapy in Left Ventricular Assist Device Patients.
    J Cardiovasc Pharmacol. 2022 Jan 17. pii: 00005344-900000000-98060.
    PubMed         Abstract available
    
    
12. BILLINGSLEY H, Dixon D, Yehya A, Carbone S, et al
    Sleeve Gastrectomy Reduces BMI and Pill Count in Patients With LVAD.
    J Cardiovasc Pharmacol. 2022;79:644-645.
    PubMed        
    
    
13. OYESOMI ET, Tabrizchi R
    Heart and Sodium-Glucose Cotransporter 2 Inhibitors: A Sodium Dilemma.
    J Cardiovasc Pharmacol. 2022;79:641-643.
    PubMed        
    
    
14. GUO Y, Xiao C, Zhao K, He Z, et al
    Physical Exercise Modalities for the Management of Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    J Cardiovasc Pharmacol. 2022;79:698-710.
    PubMed         Abstract available
    
    
15. CLEMENTS JN
    Development and Current Role of Sodium Glucose Cotransporter Inhibition in Cardiorenal Metabolic Syndrome.
    J Cardiovasc Pharmacol. 2022;79:593-604.
    PubMed         Abstract available
    
    

    
    J Mol Cell Cardiol

16. STENZIG J, Lemoine MD, Stoter AMS, Wrona KM, et al
    Recapitulation of dyssynchrony-associated contractile impairment in asymmetrically paced engineered heart tissue.
    J Mol Cell Cardiol. 2022;163:97-105.
    PubMed         Abstract available
    
    
17. ESCHENHAGEN T, Ridders K, Weinberger F
    How to repair a broken heart with pluripotent stem cell-derived cardiomyocytes.
    J Mol Cell Cardiol. 2022;163:106-117.
    PubMed         Abstract available
    
    
18. CAGGIANO LR, Holmes JW, Witzenburg CM
    Individual variability in animal-specific hemodynamic compensation following myocardial infarction.
    J Mol Cell Cardiol. 2021 Oct 28. pii: S0022-2828(21)00207.
    PubMed         Abstract available
    
    
19. TANI H, Tohyama S, Kishino Y, Kanazawa H, et al
    Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy.
    J Mol Cell Cardiol. 2022;164:83-91.
    PubMed         Abstract available
    
    
20. WANG N, Dries E, Fowler ED, Harmer SC, et al
    Inducing Ito,f and phase 1 repolarization of the cardiac action potential with a Kv4.3/KChIP2.1 bicistronic transgene.
    J Mol Cell Cardiol. 2022;164:29-41.
    PubMed         Abstract available
    
    
21. QIU Y, Pan X, Chen Y, Xiao J, et al
    Hallmarks of exercised heart.
    J Mol Cell Cardiol. 2022;164:126-135.
    PubMed         Abstract available
    
    
22. WANG C, Zhang Y, Methawasin M, Braz CU, et al
    RBM20(S639G) mutation is a high genetic risk factor for premature death through RNA-protein condensates.
    J Mol Cell Cardiol. 2022;165:115-129.
    PubMed         Abstract available
    
    
23. CHENG G, Zhu D, Huang K, Caranasos TG, et al
    Minimally invasive delivery of a hydrogel-based exosome patch to prevent heart failure.
    J Mol Cell Cardiol. 2022 May 3. pii: S0022-2828(22)00085.
    PubMed         Abstract available
    
    

    
    PLoS One

24. SHARA N, Bjarnadottir MV, Falah N, Chou J, et al
    Voice activated remote monitoring technology for heart failure patients: Study design, feasibility and observations from a pilot randomized control trial.
    PLoS One. 2022;17:e0267794.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: